Careers Media center Contacts

ANTARES




Active substance: tiazotic acid

ATC: С01Е В23.

DOSAGE FORM

10 tablets in blister, 3 or 9 blisters in a pack; 15 tablets in blister, 6 blisters in a pack.

ACTIVE INGREDIENT

1 tablet contains 200 mg of morpholine salt of tiazotic acid on 100% substance basis, equivalent to 133 mg of the tiazotic acid.

INDICATIONS

In complex treatment of ischemic heart disease: angina pectoris, myocardial infarct, postinfarction cardiosclerosis; cardiac arrhythmia. In complex treatment of chronic hepatitis of different ethiology, including alcoholic hepatitis; hepatic cirrhosis.

ATTENTION!

The following information is intended for medical and pharmaceutical professionals only and can be used exclusively in professional activities.

ARE YOU A MEDICAL AND/OR PHARMACEUTICAL PROFESSIONAL?

(submitting the answer, you bear full responsibility for the accuracy of the information provided)


The presented package image matches the product design registered with the Ukrainian regulatory authorities.

If you have noticed any differences, please call us at +380 44 490 75 22

PHARMACOVIGILANCE

If you have information about any adverse effects or other drug-related problems, please fill in the form